- Home
- PCRX vs EVRI Comparison
PCRX vs EVRI Comparison
Compare PCRX & EVRI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PCRX
- EVRI
- Stock Information
- Founded
- PCRX 2006
- EVRI 1998
- Country
- PCRX United States
- EVRI United States
- Employees
- PCRX N/A
- EVRI N/A
- Industry
- PCRX Biotechnology: Pharmaceutical Preparations
- EVRI Services-Misc. Amusement & Recreation
- Sector
- PCRX Health Care
- EVRI Consumer Discretionary
- Exchange
- PCRX Nasdaq
- EVRI Nasdaq
- Market Cap
- PCRX 1.1B
- EVRI 1.2B
- IPO Year
- PCRX 2011
- EVRI 2005
- Fundamental
- Price
- PCRX $24.91
- EVRI $13.61
- Analyst Decision
- PCRX Buy
- EVRI Hold
- Analyst Count
- PCRX 9
- EVRI 4
- Target Price
- PCRX $30.67
- EVRI $12.83
- AVG Volume (30 Days)
- PCRX 920.6K
- EVRI 1.2M
- Earning Date
- PCRX 05-06-2025
- EVRI 03-03-2025
- Dividend Yield
- PCRX N/A
- EVRI N/A
- EPS Growth
- PCRX N/A
- EVRI N/A
- EPS
- PCRX N/A
- EVRI 0.17
- Revenue
- PCRX $700,966,000.00
- EVRI $757,903,000.00
- Revenue This Year
- PCRX $9.77
- EVRI $7.73
- Revenue Next Year
- PCRX $9.83
- EVRI $2.09
- P/E Ratio
- PCRX N/A
- EVRI $80.06
- Revenue Growth
- PCRX 3.85
- EVRI N/A
- 52 Week Low
- PCRX $11.16
- EVRI $6.37
- 52 Week High
- PCRX $31.67
- EVRI $13.83
- Technical
- Relative Strength Index (RSI)
- PCRX 55.86
- EVRI 42.28
- Support Level
- PCRX $23.93
- EVRI $13.56
- Resistance Level
- PCRX $25.08
- EVRI $13.75
- Average True Range (ATR)
- PCRX 0.97
- EVRI 0.07
- MACD
- PCRX 0.20
- EVRI -0.00
- Stochastic Oscillator
- PCRX 76.05
- EVRI 46.15
About PCRX Pacira BioSciences Inc.
Pacira BioSciences Inc is a provider of non-opioid pain management and regenerative health solutions dedicated to advancing and improving outcomes for healthcare practitioners and their patients. The company's commercialized non-opioid treatments: EXPAREL a long-acting, local analgesic currently approved for postsurgical pain management; ZILRETTA, an extended-release, intra-articular, corticosteroid injection indicated for the management of osteoarthritis; and iovera, a novel, handheld device for delivering immediate, long-acting, drug-free pain control using precise, controlled doses of cold temperature to a targeted nerve. In addition, it is developing PCRX-201 (enekinragene inzadenovec), a novel gene therapy vector platform for the treatment of osteoarthritis of the knee.
About EVRI Everi Holdings Inc.
Everi Holdings Inc provides entertainment and technology solutions for the casino, interactive, and gaming industry. It operates in two segments namely Games and Financial Technology Solutions (FinTech). Enveri Games provides gaming operators with gaming technology products and services which include gaming machines, slot machines, leased gaming equipment, and other products and services. Enveri FinTech provides gaming operators with financial technology products and services which include services and equipment that facilitate casino patron's to access cash at gaming facilities through automated teller machines, point of sale debit card purchases and others.